BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amorcyte Inc. 

4 Pearl Court
Suite C
Allendale  New Jersey  07401  U.S.A.
Phone: 908-510-0617 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
NeoStem, Inc. Subsidiary, Amorcyte Inc., Announces Significant Expansion in Its Claims Granted to Protect the Use of CD34+ Cells 9/10/2012 9:08:27 AM
Amorcyte Inc., a NeoStem, Inc. Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction 1/25/2012 10:47:43 AM
Amorcyte Inc., a NeoStem, Inc. Company, Announces Expansion of Intellectual Property Coverage 1/10/2012 10:17:59 AM
NeoStem, Inc. Closes Amorcyte Inc. Acquisition 10/18/2011 7:00:46 AM
NeoStem, Inc. Provides Update on Amorcyte Inc. Clinical Progress and Reports Results for Second Quarter 8/15/2011 11:24:09 AM
NeoStem, Inc. Signs Definitive Merger Agreement to Acquire Amorcyte Inc. in Equity Transaction 7/15/2011 5:51:00 AM
Amorcyte Inc. Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients 12/21/2010 7:45:57 AM
Amorcyte Inc. Granted Landmark Patent 9/13/2010 9:12:18 AM
Amorcyte Inc. Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at American College of Cardiology Annual Scientific Session 3/30/2009 8:16:06 AM
Amorcyte Inc. Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction 4/1/2008 11:26:20 AM
12